imatinib
CHEBI:CHEBI_45783
Definition
A benzamide obtained by formal condensation of the carboxy group of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid with the primary aromatic amino group of 4-methyl-N(3)-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine. Used (as its mesylate salt) for treatment of chronic myelogenous leukemia and gastrointestinal stromal tumours.
Chemical Information
- Molecular Formula
- C29H31N7O
- Molecular Mass
- 493.60270
- Charge
- 0
- SMILES
- CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1
- InChI
- InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)
- InChIKey
- KTUFNOKKBVMGRW-UHFFFAOYSA-N
Alternative Names
- 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE
- 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide
- alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-toluidide
- imatinib
- STI 571
Treatment Applications
Drug Classification
-
benzamidesView Class →
CHEBI:22702
-
pyrimidinesView Class →
CHEBI:39447
-
pyridinesView Class →
CHEBI:26421
-
aromatic amineView Class →
CHEBI:33860
-
N-methylpiperazineView Class →
CHEBI:46920
-
t221046
-
t221228
-
t221314
-
t221490
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:45783
- DRON_00010000
- 282388
- oboInOwl#hasDbXref
- Wikipedia:Imatinib
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- brand_name_base
- Gleevec
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- dosage_form
- POWDER
- labeler_name
- Valary Lab Private Limited
- product_ndc
- 62068-309
- application_number
- ANDA204285
- brand_name
- imatinib mesylate
- core#notation
- CHEBI:45783
- rxcui
- 404589
- active_ingredient_strength
- 640 kg/640kg
- pharm_class
- Bcr-Abl Tyrosine Kinase Inhibitors [MoA]
- active_ingredient_name
- IMATINIB
- unii
- 8A1O1M485B
- spl_set_id
- a819a954-41c9-4d49-a74e-c8c4b338b22a
- upc
- 0372485203307
- manufacturer_name
- Chartwell RX, LLC
- brand_name_suffix
- 400 mg
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- package_description
- 18 kg in 1 DRUM (62068-309-02)
- package_ndc
- 72485-202-90
- package_marketing_start_date
- 10-MAR-15
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 282388
- oboInOwl#hasDbXref
- Wikipedia:Imatinib
- oboInOwl#hasAlternativeId
- CHEBI:45781
- oboInOwl#id
- CHEBI:45783
- generic_name
- IMATINIB BASE
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_68495
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- chebi#has_functional_parent
- http://purl.obolibrary.org/obo/CHEBI_28179
- listing_expiration_date
- 20241231
- marketing_start_date
- 20030518
- spl_id
- 5c50ce9c-60b0-4293-a6f9-72cd302949a7
- has_treatment
- http://purl.obolibrary.org/obo/DOID_2668
- route
- ORAL
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_111447
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect24598
- owl#annotatedSource
- t221501
- owl#someValuesFrom
- t947388